Therapeutic Outcomes and Clinical Features of Advanced Non–Small Cell Lung Cancer Carrying KRAS Mutations: A Multicenter Real-life Retrospective Study

G Mazzaschi, F Perrone, R Minari, M Verzè… - Clinical Lung Cancer, 2022 - Elsevier
Abstract Introduction Targeting Kirsten Rat Sarcoma (KRAS) has been deemed impossible
for long time, but new drugs have recently demonstrated promising results. Evidence on the …
被引用次数：2 相关文章

Therapeutic Outcomes and Clinical Features of Advanced Non-Small Cell Lung Cancer Carrying KRAS Mutations: A Multicenter Real-life Retrospective Study

G Mazzaschi, F Perrone, R Minari… - Clinical lung …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction Targeting Kirsten Rat Sarcoma (KRAS) has been deemed impossible for long
time, but new drugs have recently demonstrated promising results. Evidence on the outcome …

Therapeutic Outcomes and Clinical Features of Advanced Non-Small Cell Lung Cancer Carrying KRAS Mutations: A Multicenter Real-life Retrospective Study.

G Mazzaschi, F Perrone, R Minari, M Verzè… - Clinical Lung …, 2022 - europepmc.org
Materials and methods The present multicenter retrospective study, conducted by 5 Italian
Centers from January 2018 to February 2020, involved 297 advanced KRAS mutant …

Therapeutic Outcomes and Clinical Features of Advanced Non-Small Cell Lung Cancer Carrying KRAS Mutations: A Multicenter Real-life Retrospective Study

G Mazzaschi, F Perrone, R Minari, M Verzè… - CLINICAL LUNG …, 2022 - air.unipr.it
Targeting Kirsten Rat Sarcoma (KRAS) has been deemed impossible for long time, but new
drugs have recently demonstrated promising results. Evidence on the outcome of KRAS …

Therapeutic Outcomes and Clinical Features of Advanced Non–Small Cell Lung Cancer Carrying KRAS Mutations: A Multicenter Real-life Retrospective Study

G Mazzaschi, F Perrone, R Minari… - Clinical Lung …, 2022 - clinical-lung-cancer.com
Abstract Introduction Targeting Kirsten Rat Sarcoma (KRAS) has been deemed impossible
for long time, but new drugs have recently demonstrated promising results. Evidence on the …

Therapeutic Outcomes and Clinical Features of Advanced Non–Small Cell Lung Cancer Carrying KRAS Mutations: A Multicenter Real-life Retrospective Study

G Mazzaschi, F Perrone, R Minari… - Clinical Lung …, 2022 - clinical-lung-cancer.com
Abstract Introduction Targeting Kirsten Rat Sarcoma (KRAS) has been deemed impossible
for long time, but new drugs have recently demonstrated promising results. Evidence on the …